OncoTraj releases a harmonized 813-patient dataset with audited splits for three tasks on osimertinib resistance, showing single-timepoint NGS features yield no model above chance while recovering a TP53 association.
Maron, Mohamed Ahmed, Susie Kim, Mono Pirun, Walid K
2 Pith papers cite this work. Polarity classification is still indexing.
2
Pith papers citing it
years
2026 2verdicts
UNVERDICTED 2representative citing papers
Multimodal model fuses radiology-report semantics and host-response lab biomarkers to predict lung cancer survival, reporting C-indices of 0.920 (train) and 0.849 (test) in a retrospective two-center cohort of 574 patients.
citing papers explorer
-
OncoTraj: a public benchmark for longitudinal resistance prediction in EGFR-mutant non-small-cell lung cancer on osimertinib
OncoTraj releases a harmonized 813-patient dataset with audited splits for three tasks on osimertinib resistance, showing single-timepoint NGS features yield no model above chance while recovering a TP53 association.